Medical Marijuana Companies Sue DEA In Federal Court Over Restrictions It Imposed For Rescheduling Protections
7 Articles
7 Articles
Marijuana Rescheduling Makes Strange Bedfellows: MMJ and State Operators Take Their Battles to Federal Court
Duane Boise, President and CEO of MMJ International Holdings, Noted: "In Marijuana State Operators Own Sworn Court Filings, the Operators Acknowledge Building Multimillion-Dollar Supply Chains for Years Without Federal DEA Registrations-Now They Are Turning to Federal Judges to Protect the…
Medical Marijuana Companies Sue DEA In Federal Court Over Restrictions It Imposed For Rescheduling Protections
Three marijuana companies are taking the Drug Enforcement Administration (DEA) to court over restrictions the agency is placing on cannabis businesses under the Trump administration’s federal rescheduling move. Last month, DEA announced it had granted federal registration and protections to hundreds of medical marijuana businesses in line with rescheduling while also issuing new guidance warning […]
Federal Rescheduling Gridlock: Medical Cannabis Operators File Second Lawsuit Against DEA Over Supply Chain Rules
A second lawsuit from vertically integrated medical cannabis operators accuses the DEA of destabilizing state markets through tight supply chain restrictions tied to federal rescheduling.
Back to the Deadline: Medical Marijuana Operators Ask a Court to Pause DEA’s Supply-Chain Rules
Doc Brown had a time machine (out of a DeLorean?!?!) for dealing with inconvenient timelines. Medical marijuana operators have lawyers. Less cinematic, certainly, but the latest dispute over DEA’s implementation of rescheduling also turns on a date that could change what happens next. Three companies have taken that question to the U.S. Court of Appeals...
Medical Marijuana Companies Sue DEA In Federal Court Over Restrictions
Three medical marijuana companies are suing the DEA in federal court over the restrictions it imposed for rescheduling protections. Our 🔥-TAKE: Medical cannabis companies are now litigating to lock in the real-world benefits of Schedule III, proving the industry has both the legal firepower and the economic incentive to stop the DEA from quietly gutting […]
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium









